ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,593Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 113

$480K Total Retail Price of All Prescriptions

Rank: 34 out of 113

284 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 284 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 284 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 7,670 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 359 350 1 1
SIMVASTATIN 341 299 2 2
FUROSEMIDE 322 301 3 6
LISINOPRIL 314 293 4 3
OMEPRAZOLE 298 246 5 5
AMLODIPINE BESYLATE 254 236 6 4
WARFARIN SODIUM 229 186 7 8
SERTRALINE HCL 186 186 8 21
DIGOXIN 171 171 9 27
METOPROLOL TARTRATE 169 154 10 14
GABAPENTIN 167 161 11 18
POTASSIUM CHLORIDE 166 166 12 12
FENTANYL 154 147 S2 13 43
METOPROLOL SUCCINATE 149 143 14 10
TAMSULOSIN HCL 138 126 15 24
HYDROCODONE-ACETAMINOPHEN 136 126 S3 16 7
OLANZAPINE 135 96 17 88
ATENOLOL 127 119 18 16
LOSARTAN POTASSIUM 127 108 18 13
METFORMIN HCL 112 105 20 11
QUETIAPINE FUMARATE 109 89 21 83
ALLOPURINOL 105 92 22 20
DOXAZOSIN MESYLATE 100 100 23 49
HYDROCHLOROTHIAZIDE 99 81 24 9
ADVAIR DISKUS 95 88 25 35
NAMENDA 88 88 26 48
SPIRIVA 84 82 27 54
DIVALPROEX SODIUM 77 21 28 97
ZOLPIDEM TARTRATE 76 73 29 19
SPIRONOLACTONE 76 76 29 32
LANTUS 72 62 31 38
GLIMEPIRIDE 66 66 32 36
PHENYTOIN SODIUM EXTENDED 65 43 33 140
DONEPEZIL HCL 65 65 33 33
LOSARTAN-HYDROCHLOROTHIAZIDE 63 63 35 40
DILTIAZEM 24HR CD 62 55 36 149
POLYETHYLENE GLYCOL 3350 61 59 37 77
RISPERIDONE 60 50 38 134
MELOXICAM 60 60 38 44
OLANZAPINE ODT 57 0 40 188
CLOPIDOGREL 57 52 40 56
CARVEDILOL 55 55 42 25
RANITIDINE HCL 55 44 42 96
LATANOPROST 52 49 44 199
EVISTA 51 51 45 119
CIPROFLOXACIN HCL 51 51 45 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.